HomeCompareSBTX vs PLD

SBTX vs PLD: Dividend Comparison 2026

SBTX yields 34.07% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.74M in total portfolio value· pulled ahead in Year 7
10 years
SBTX
SBTX
● Live price
34.07%
Share price
$5.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$24,647.82
Full SBTX calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — SBTX vs PLD

📍 PLD pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBTXPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBTX + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBTX pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBTX
Annual income on $10K today (after 15% tax)
$2,896.08/yr
After 10yr DRIP, annual income (after tax)
$20,950.65/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,017,165.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBTX + PLD for your $10,000?

SBTX: 50%PLD: 50%
100% PLD50/50100% SBTX
Portfolio after 10yr
$3.04M
Annual income
$2,387,686.50/yr
Blended yield
78.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

SBTX
Analyst Ratings
5
Hold
Consensus: Hold
Altman Z
-0.3
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBTX buys
0
PLD buys
0
No recent congressional trades found for SBTX or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBTXPLD
Forward yield34.07%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$167.0K$5.91M
Annual income after 10y$24,647.82$4,750,725.19
Total dividends collected$119.3K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: SBTX vs PLD ($10,000, DRIP)

YearSBTX PortfolioSBTX Income/yrPLD PortfolioPLD Income/yrGap
1$14,107$3,407.16$11,241$540.96+$2.9KSBTX
2$19,587$4,492.08$13,019$991.13+$6.6KSBTX
3$26,787$5,828.90$15,801$1,870.97+$11.0KSBTX
4$36,112$7,450.06$20,609$3,701.21+$15.5KSBTX
5$48,026$9,386.56$29,919$7,867.97+$18.1KSBTX
6$63,055$11,666.79$50,631$18,617.74+$12.4KSBTX
7← crossover$81,784$14,315.54$105,528$51,352.20$23.7KPLD
8$104,862$17,353.02$287,364$174,449.42$182.5KPLD
9$132,997$20,794.11$1,081,760$774,280.77$948.8KPLD
10$166,954$24,647.82$5,908,209$4,750,725.19$5.74MPLD

SBTX vs PLD: Complete Analysis 2026

SBTXStock

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Full SBTX Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this SBTX vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBTX vs SCHDSBTX vs JEPISBTX vs OSBTX vs KOSBTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.